Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Stuckey

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 23, 2016
On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injuryMark A Cole, Amira H Abd Jamil, Lisa C Heather, et al.
The Biochemical Journal|June 22, 2022
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responsesJacqueline J T Marshall, Joshua J Cull, Hajed O Alharbi, et al.
JCI Insight|August 9, 2021
In vivo grafting of large engineered heart tissue patches for cardiac repairRichard J Jabbour, Thomas J Owen, Pragati Pandey, et al.
JMIR Research Protocols|October 4, 2019
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver MalignanciesLaura Beaton, Henry F J Tregidgo, Sami A Znati, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 8, 2022
Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver MalignanciesLaura Beaton, Henry F J Tregidgo, Sami A Znati, et al.
Science Translational Medicine|April 1, 2016
Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humansSandra D Castillo, Elena Tzouanacou, May Zaw-Thin, et al.
Cell Stem Cell|March 7, 2020
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In VivoLorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Cell Stem Cell|March 12, 2019
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In VivoLorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 23, 2016
On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injuryMark A Cole, Amira H Abd Jamil, Lisa C Heather, et al.
The Biochemical Journal|June 22, 2022
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responsesJacqueline J T Marshall, Joshua J Cull, Hajed O Alharbi, et al.
JCI Insight|August 9, 2021
In vivo grafting of large engineered heart tissue patches for cardiac repairRichard J Jabbour, Thomas J Owen, Pragati Pandey, et al.
JMIR Research Protocols|October 4, 2019
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver MalignanciesLaura Beaton, Henry F J Tregidgo, Sami A Znati, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 8, 2022
Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver MalignanciesLaura Beaton, Henry F J Tregidgo, Sami A Znati, et al.
Science Translational Medicine|April 1, 2016
Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humansSandra D Castillo, Elena Tzouanacou, May Zaw-Thin, et al.
Cell Stem Cell|March 7, 2020
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In VivoLorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Cell Stem Cell|March 12, 2019
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In VivoLorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Pageof 8